Kennethmoch
Client
Joined October 2022
ContestContests
Logos
Status
Prize *
Ternalys Therapeutics
Ternalys is an early stage biotechnology/drug development company developing a new technology (microRNA Clusters) for the treatment of intractable cancers such as glioblastoma (brain cancer)
Target audience will be investors and the financial community
237
Logos
Complete
Status
$275
Prize
Ternalys Therapeutics
Ternalys is an early stage biotechnology/drug development company developing a new technology (microRNA Clusters) for the treatment of intractable cancers such as glioblastoma (brain cancer)
Target audience will be investors and the financial community
237
Complete
$275
* The Prize Package includes the Designer prize and all LogoTournament fees.